𝔖 Bobbio Scriptorium
✦   LIBER   ✦

cDNA microarray-based translational research in soft tissue sarcoma

✍ Scribed by Joanna M. Lubieniecka; Torsten O. Nielsen

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
71 KB
Volume
92
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

✦ Synopsis

The authors discuss application of cDNA microarray technology in translational research to identify diagnostic markers and therapeutic targets in adult soft tissue sarcoma. Recent results in synovial sarcoma are used to highlight the applicability of this technology for marker and target discovery, as well as the need for preclinical validation of putative therapeutic targets.

πŸ“œ SIMILAR VOLUMES

Metastatic nonrhabdomyosarcomatous soft-
Metastatic nonrhabdomyosarcomatous soft-tissue sarcomas in children and adolescents: The St. Jude Children's Research Hospital experience
✍ Pappo, Alberto S.; Rao, Bhaskar N.; Jenkins, Jesse J.; Merchant, Thomas; Poquett πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 79 KB πŸ‘ 3 views

## Background. Because the natural history of pediatric patients with metastatic nonrhabdomyosarcomatous soft-tissue sarcomas (NRSTS) had not been well described, we retrospectively reviewed our single-institution experience with these tumors. Procedure. We identified 26 patients with metastatic N

Patterns of care in a population-based s
Patterns of care in a population-based sample of soft tissue sarcoma patients in the United States
✍ Shirish M. Gadgeel; Linda C. Harlan; Christopher A. Zeruto; Michael Osswald; Ann πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 137 KB πŸ‘ 1 views

## Abstract ## BACKGROUND: Soft tissue sarcomas (STS) are relatively uncommon tumors. Data regarding the patterns of care of patients with STS and its consistency with available guidelines are relatively sparse. The authors conducted a detailed analysis of STS patients diagnosed in 2002 and sample

PML expression in soft tissue sarcoma: P
PML expression in soft tissue sarcoma: Prognostic and predictive value in alkylating agents/antracycline-based first line therapy
✍ Bruno Vincenzi; Daniele Santini; Gaia Schiavon; Anna Maria Frezza; Marianna Sill πŸ“‚ Article πŸ“… 2012 πŸ› John Wiley and Sons 🌐 English βš– 208 KB

## Abstract Soft tissue sarcomas are aggressive tumors representing <1% of all adult neoplasms. Aim of our study was to evaluate promyelocytic leukemia gene expression value as prognostic factor and as a factor predicting response to alkylating agents/antracycline‐based first line therapy. One hund